Boron neutron capture therapy of cancer: where do we stand now?

被引：3
|
作者：
Barth, Rolf F. [1 ]
Wu, Gong [2 ]
Vicente, Maria da Graca H. [3 ]
Grecula, John C. [4 ]
Gupta, Nilendu [4 ]
机构：
[1] Ohio State Univ, Dept Pathol, Columbus, OH USA
[2] Ohio State Univ, Mass Spectrometry & Prote Facil, Columbus, OH USA
[3] Louisiana State Univ, Dept Chem, Baton Rouge, LA USA
[4] Ohio State Univ, Dept Radiat Oncol, Columbus, OH 43210 USA
来源：
CANCER COMMUNICATIONS | 2024年 / 44卷 / 08期
关键词：
BIODISTRIBUTION;
D O I：
10.1002/cac2.12581
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：889 / 892
页数：4
相关论文
共 50 条
  • [21] Precision diabetology: Where do we stand now?
    Manfredi, Christian Herder
    Rizzo, Manfredi
    Roden, Michael
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2024, 38 (12)
  • [22] Laparoscopic Adrenalectomy: Where Do We Stand Now?
    Karanikola, Evridiki
    Tsigris, Christos
    Kontzoglou, Konstantinos
    Nikiteas, Nikolaos
    TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 2010, 220 (04): : 259 - 265
  • [23] HRT 2004: Where do we stand now
    Pines, A
    ISRAEL MEDICAL ASSOCIATION JOURNAL, 2004, 6 (10): : 642 - 643
  • [24] HDL Hypothesis: Where Do We Stand Now?
    Sayed M. Tariq
    Mandeep S. Sidhu
    Peter P. Toth
    William E. Boden
    Current Atherosclerosis Reports, 2014, 16
  • [25] The 'oestrogen hypothesis' - where do we stand now?
    Sharpe, RM
    INTERNATIONAL JOURNAL OF ANDROLOGY, 2003, 26 (01): : 2 - 15
  • [26] An insight into iTRAQ: where do we stand now?
    Caroline Evans
    Josselin Noirel
    Saw Yen Ow
    Malinda Salim
    Ana G. Pereira-Medrano
    Narciso Couto
    Jagroop Pandhal
    Duncan Smith
    Trong Khoa Pham
    Esther Karunakaran
    Xin Zou
    Catherine A. Biggs
    Phillip C. Wright
    Analytical and Bioanalytical Chemistry, 2012, 404 : 1011 - 1027
  • [27] Biologics in vasculitides: Where do we stand, where do we go from now?
    Pazzola, Giulia
    Muratore, Francesco
    Pipitone, Nicolo
    Salvarani, Carlo
    PRESSE MEDICALE, 2015, 44 (06): : E231 - E239
  • [28] Particle therapy in lung cancer: Where do we stand?
    Pijls-Johannesmata, Madelon
    Grutters, Janneke P. C.
    Lambin, Philippe
    De Ruysscher, Dirk
    CANCER TREATMENT REVIEWS, 2008, 34 (03) : 259 - 267
  • [29] Consolidation therapy in ovarian cancer: Where do we stand?
    Dearnley, Daynelle D.
    McMeekin, D. Scott
    CURRENT OPINION IN OBSTETRICS & GYNECOLOGY, 2006, 18 (01) : 3 - 7
  • [30] Gene therapy for thyroid cancer: Where do we stand?
    DeGroot, LJ
    Zhang, RS
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (07): : 2923 - 2928
12345